New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.

Yamamura, Jun; Kamigaki, Shunji; Fujita, Junya; Osato, Hiroki; Manabe, Hironobu; Tanaka, Yumiko; Shinzaki, Wataru; Hashimoto, Yukihiko; Komoike, Yoshifumi

Yamamura, Jun; Kamigaki, Shunji; Fujita, Junya; Osato, Hiroki; Manabe, Hironobu; Tanaka, Yumiko; Shinzaki, Wataru; Hashimoto, Yukihiko; Komoike, Yoshifumi.

Afiliação

Yamamura J; Department of Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai City, Osaka, 593-8304, Japan. june10th68@gmail.com.
Kamigaki S; Division of Breast and Endocrine Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2, Ohnohigasi, Sayama City, Osaka, 589-8511, Japan. june10th68@gmail.com.
Fujita J; Department of Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai City, Osaka, 593-8304, Japan.
Osato H; Department of Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai City, Osaka, 593-8304, Japan.
Manabe H; Department of Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai City, Osaka, 593-8304, Japan.
Tanaka Y; Division of Breast and Endocrine Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2, Ohnohigasi, Sayama City, Osaka, 589-8511, Japan.
Shinzaki W; Division of Breast and Endocrine Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2, Ohnohigasi, Sayama City, Osaka, 589-8511, Japan.
Hashimoto Y; Division of Breast and Endocrine Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2, Ohnohigasi, Sayama City, Osaka, 589-8511, Japan.
Komoike Y; Division of Breast and Endocrine Surgery, Department of Surgery, Kindai University Faculty of Medicine, 377-2, Ohnohigasi, Sayama City, Osaka, 589-8511, Japan.

BMC Cancer ; 21(1): 476, 2021 Apr 29.

Article em En | MEDLINE | ID: mdl-33926418

Assuntos

Neoplasias da Mama/mortalidade; Neoplasias da Mama/patologia; Recidiva Local de Neoplasia/mortalidade; Receptores de Estrogênio; Receptores de Progesterona; Adulto; Idoso; Idoso de 80 Anos ou mais; Neoplasias Ósseas/mortalidade; Neoplasias Ósseas/secundário; Neoplasias Encefálicas/mortalidade; Neoplasias Encefálicas/secundário; Neoplasias da Mama/química; Intervalo Livre de Doença; Feminino; Humanos; Estimativa de Kaplan-Meier; Neoplasias Hepáticas/mortalidade; Neoplasias Hepáticas/secundário; Neoplasias Pulmonares/mortalidade; Neoplasias Pulmonares/secundário; Metástase Linfática; Pessoa de Meia-Idade; Recidiva Local de Neoplasia/química; Neoplasias Pleurais/mortalidade; Neoplasias Pleurais/secundário; Prognóstico; Receptor ErbB-2; Estudos Retrospectivos

Palavras-chave

Breast cancer; HER2-negative; Hormone receptor-positive; Metastatic pattern; Recurrence; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Progesterona / Receptores de Estrogênio / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google